Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigida Barberio

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2026
Efficacy of Biological and Steroid Therapies in Adolescent and Adult Patients with Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis with Meta-regressionMohammad Al Hayek, Alfredo J Lucendo, Edoardo Vincenzo Savarino, et al.
Scientific Reports|May 15, 2021
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originatorLinda Cingolani, Brigida Barberio, Fabiana Zingone, et al.
Journal of Crohn'S & Colitis|February 23, 2023
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case SeriesDavide Giuseppe Ribaldone, Sophie Vieujean, Mette Julsgaard, et al.
Cancers|June 2, 2021
Prevention Strategies for Esophageal Cancer-An Expert ReviewElisa Marabotto, Gaia Pellegatta, Afscin Djahandideh Sheijani, et al.
Therapeutic Advances in Gastroenterology|December 23, 2024
Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease managementLuisa Bertin, Martina Crepaldi, Miriana Zanconato, et al.
Clinical and Experimental Gastroenterology|October 15, 2024
Refractory Crohn's Disease: Perspectives, Unmet Needs and InnovationsLuisa Bertin, Martina Crepaldi, Miriana Zanconato, et al.
Eclinicalmedicine|March 2, 2026
Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for erosive esophagitis: a network meta-analysis of randomized controlled trialsMohammad Al Hayek, Alfredo J Lucendo, Brigida Barberio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2020
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic EsophagitisMatteo Ghisa, Giorgio Laserra, Elisa Marabotto, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 28, 2023
Artificial Intelligence Tools for the Diagnosis of Eosinophilic Esophagitis in Adults Reporting Dysphagia: Development, External Validation, and Software Creation for Point-of-Care UsePierfrancesco Visaggi, Giulio Del Corso, Federica Baiano Svizzero, et al.
Therapeutic Advances in Gastroenterology|August 5, 2021
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian studyBrigida Barberio, Linda Cingolani, Cristina Canova, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2026
Efficacy of Biological and Steroid Therapies in Adolescent and Adult Patients with Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis with Meta-regressionMohammad Al Hayek, Alfredo J Lucendo, Edoardo Vincenzo Savarino, et al.
Scientific Reports|May 15, 2021
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originatorLinda Cingolani, Brigida Barberio, Fabiana Zingone, et al.
Journal of Crohn'S & Colitis|February 23, 2023
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case SeriesDavide Giuseppe Ribaldone, Sophie Vieujean, Mette Julsgaard, et al.
Cancers|June 2, 2021
Prevention Strategies for Esophageal Cancer-An Expert ReviewElisa Marabotto, Gaia Pellegatta, Afscin Djahandideh Sheijani, et al.
Therapeutic Advances in Gastroenterology|December 23, 2024
Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease managementLuisa Bertin, Martina Crepaldi, Miriana Zanconato, et al.
Clinical and Experimental Gastroenterology|October 15, 2024
Refractory Crohn's Disease: Perspectives, Unmet Needs and InnovationsLuisa Bertin, Martina Crepaldi, Miriana Zanconato, et al.
Eclinicalmedicine|March 2, 2026
Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for erosive esophagitis: a network meta-analysis of randomized controlled trialsMohammad Al Hayek, Alfredo J Lucendo, Brigida Barberio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2020
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic EsophagitisMatteo Ghisa, Giorgio Laserra, Elisa Marabotto, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 28, 2023
Artificial Intelligence Tools for the Diagnosis of Eosinophilic Esophagitis in Adults Reporting Dysphagia: Development, External Validation, and Software Creation for Point-of-Care UsePierfrancesco Visaggi, Giulio Del Corso, Federica Baiano Svizzero, et al.
Therapeutic Advances in Gastroenterology|August 5, 2021
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian studyBrigida Barberio, Linda Cingolani, Cristina Canova, et al.
Pageof 14